Coventry Health Care Adds Second State to Catasys Program
LOS ANGELES, CALIFORNIA — December 1, 2011 — Catasys, Inc. (CATS)
announced today that it has entered into a multi-year agreement with
Coventry Health Care of Louisiana, Inc., a subsidiary of Coventry Health
Care Inc., to provide the OnTrak™ integrated substance
dependence solution to its commercial members. This represents the
second region of Coventry Health Care, one of the country’s largest
health insurance companies, to adopt OnTrak. Program is expected to launch in January of 2012.
Eligible commercial members of Coventry Health
Care of Louisiana affected by substance dependence will be covered under
the Catasys program, which includes medical and psychosocial
interventions, as well as care coaching over a 52 week period. Coventry
Health Care of Louisiana will pay Catasys monthly payments covering
enrolled members’ OnTrak treatment program. Catasys will enroll
eligible members directly and also in conjunction with health plan
programs and staff.
“We are pleased to be expanding into our second
Coventry region with Coventry Health Care of Louisiana,” said Rick
Anderson, Catasys President and COO, “and we look forward to delivering
better clinical and financial outcomes for its members. We hope to
continue to expand OnTrak among other Coventry plans. After three
years of transitioning to the Catasys business model, and given the
long sales cycle with health plans, as we close out the year and enter
the new year we believe additional contracts will be consummated from
our pipeline.”
About Catasys
Catasys, Inc. provides specialized health management services to health plans, employers and unions through a network of licensed and company managed health care providers. The Catasys substance dependence program was designed to address substance dependence as a chronic disease. The program seeks to lower costs and improve member health through the delivery of integrated medical and psychosocial interventions in combination with long term care coaching, including their proprietary treatment program for alcoholism and stimulant dependence. For further information, please visit www.catasyshealth.com.
Forward-Looking Statements
Except
for statements of historical fact, the matters discussed in this press
release are forward looking and made pursuant to the Safe Harbor
provisions of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements reflect numerous assumptions and
involve a variety of risks and uncertainties, many of which are beyond
the company's control that may cause actual results to differ materially
from stated expectations. These risk factors include, among others,
changes in regulations or issuance of new regulations or
interpretations, limited operating history and lack of outcomes and
statistically significant formal research studies, difficulty enrolling
members in our programs, the risk that treatment programs might not be
effective, difficulty in developing, exploiting and protecting
proprietary technologies, intense competition and substantial regulation
in the health care industry; and additional risks factors as discussed
in the reports filed by the company with the Securities and Exchange
Commission, which are available on its website at http://www.sec.gov
Contact:
Patricia Rouhafza
Catasys, Inc.
(310) 444-4333
|